文献速递流行病学与生物统计真实世界研究与卫生经济

英国质量与结果框架按绩效付费项目对初级保健质量的影响:系统综述与定量合成

Effect of UK Quality and Outcomes Framework pay-for-performance programme on quality of primary care: systematic review with quantitative synthesis.
PubMed 文献 · BMJ · 2025-06-25

该系统综述纳入30项研究(11项可定量合成),评估英国质量与结果框架激励引入与撤除对初级保健质量的影响。引入激励后1年记录质量中位改善6.1个百分点,3年改善不一致(中位0.7个百分点);撤除激励后1年和3年记录质量分别中位下降10.7和12.8个百分点,撤除后的下降幅度一般匹配或超过引入后的增益。

要点

  • 引入激励后1年记录质量中位改善6.1个百分点,3年改善不一致。
  • 撤除激励后1年和3年记录质量分别中位下降10.7和12.8个百分点。
  • 复杂过程指标(如糖尿病足筛查)变化最大,简单过程指标变化较小。

核心结论

  • 质量与结果框架激励在1年时持续改善医疗质量,超出激励前趋势预测;但3年时影响不一致,且不明确优于趋势。
  • 激励带来的增益在激励撤除后似乎逆转。

研究设计与样本

  • 系统综述与定量合成,检索MEDLINE、Embase、CINAHL、PsycINFO和Scopus数据库,检索时间从2004年1月1日至2024年9月3日。
  • 纳入采用重复横断面或队列设计、在激励引入或撤除前后测量一致的研究;至少有三个时间点的研究纳入定量合成。
  • 共纳入30项研究,其中11项提供数据用于定量合成。
  • 偏倚风险使用混合方法评估工具(Mixed Methods Assessment Tool)评估。
  • 不适用Meta分析;通过报告中位数和四分位距(IQR)或叙述性报告进行定量合成。

主要发现

  • 引入激励后1年,83个指标记录质量中位变化为6.1个百分点(IQR 1.9至14.6),优于激励前趋势预测。
  • 引入激励后3年,72个指标记录质量中位变化为0.7个百分点(IQR -2.1至8.9),改善不一致。
  • 激励前一年绩效较低的过程指标,引入激励后影响更大。
  • 撤除激励后1年,31个指标记录质量中位变化为-10.7个百分点(IQR -17.9至-3.8);3年时31个指标中位变化为-12.8个百分点(IQR -21.0至-4.4)。
  • 对于同时有引入和撤除数据的14个指标,3年时引入激励中位变化为增加1.4个百分点(IQR -0.9至4.6),撤除激励中位变化为下降3.9个百分点(IQR 2.2至11.6)。

关键数值与推荐

  • 引入激励后1年:83个指标,中位变化6.1个百分点(IQR 1.9至14.6)。
  • 引入激励后3年:72个指标,中位变化0.7个百分点(IQR -2.1至8.9)。
  • 撤除激励后1年:31个指标,中位变化-10.7个百分点(IQR -17.9至-3.8)。
  • 撤除激励后3年:31个指标,中位变化-12.8个百分点(IQR -21.0至-4.4)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To systematically review the one and three year impact on quality of care of the introduction and withdrawal of financial incentives in the UK Quality and Outcomes Framework pay-for-performance programme. DESIGN: Systematic review with quantitative synthesis. DATA SOURCES: MEDLINE, Embase, CINAHL, PsycINFO, and Scopus databases were searched from 1 January 2004 to 3 September 2024. STUDY SELECTION: Eligible studies used repeated cross sectional or cohort designs with consistent measurement before and after incentive introduction or withdrawal. Studies with a minimum of three time points before and after intervention were included in quantitative synthesis. DATA EXTRACTION: Analysis used both reported impact if available and de novo interrupted time series analysis of extracted raw data if not reported by the original study. DATA SYNTHESIS: Meta-analysis was not appropriate; findings were quantitatively synthesised by reporting medians and interquartile ranges of changes in quality or reported narratively. Risk of bias was assessed using the Mixed Methods Assessment Tool. RESULTS: 30 studies were included, with 11 providing data for quantitative synthesis. Across all indicators, evidence was found of improvement in recorded quality at one year after incentive introduction (83 indicators; median change compared with that predicted by pre-incentivisation trends 6.1 (interquartile range (IQR) 1.9 to 14.6) percentage points) but less consistently at three years (72 indicators; median change 0.7 (-2.1 to 8.9) percentage points). Impact was higher for process indicators with lower performance in the year before incentivisation. Incentive withdrawal was associated with reduction in recorded quality compared with predicted at both one year (31 indicators; median change -10.7 (IQR -17.9 to -3.8) percentage points) and three years (31 indicators; median change -12.8 (-21.0 to -4.4) percentage points). The largest changes with both incentive introduction and withdrawal were for complex process indicators such as diabetes foot screening, with smaller changes in simple processes such as blood pressure measurement, intermediate outcomes, and treatment indicators. For all types of indicators, the reduction in quality following incentive withdrawal generally matched or exceeded the gains observed after incentive introduction (for example, for 14 indicators with data for both, median change at three years for incentive introduction was a 1.4 (IQR -0.9 to 4.6) percentage point increase versus a 3.9 (IQR 2.2 to 11.6) decrease for incentive withdrawal). CONCLUSION: Quality and Outcomes Framework incentives consistently improved quality of care at one year beyond that predicted by pre-incentivisation trends, but by three years the impact was inconsistent and not clearly better than trend. Gains from incentivisation seemed to reverse after incentive withdrawal. STUDY REGISTRATION: Prospero CRD42023467627.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Ho L, Mercer SW, Henderson D, et al. Effect of UK Quality and Outcomes Framework pay-for-performance programme on quality of primary care: systematic review with quantitative synthesis. BMJ. 2025. PMID: 40562441. doi:10.1136/bmj-2024-083424

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。